Driving API Success: Key Considerations for NCE Development and Manufacturing
Watch our expert webinar and accelerate your API journey
Developing and manufacturing a new chemical entity (NCE) is a complex journey that requires strategic planning, technical expertise, and the right industrial partner. Our webinar, “Driving API Success: Key Considerations for NCE Development and Manufacturing,” brings together specialists from Seqens to share practical insights, real case studies, and proven strategies to secure and accelerate API development from earlystage research to commercial production.
Hosted by Juliette Martin, Scientific Communication Manager, the session features contributions from Boris Gaillard, Business Projects Manager, and Ronan Rocle, Business Development Manager. Together, they guide you through the critical steps that shape a successful API program and reveal how Seqens supports customers throughout the entire lifecycle of their molecule.
From early drug candidates to commercial APIs: what you will learn
The webinar explores the essential considerations at each stage of API development, including process design, scaleup, analytical development, and industrial manufacturing. Drawing on Seqens’ extensive experience, the speakers highlight common challenges and the strategies implemented to derisk projects, optimize timelines, and ensure longterm supply reliability.
A key part of the session focuses on a realworld case study illustrating how Seqens redesigned a highly complex and costly process. By replacing a −70°C reaction with an ambienttemperature alternative and substituting palladium with a nickel catalyst—1,500 times less expensive—the team achieved:
- 70% cost reduction on a key intermediate
- Hundreds of kilograms successfully manufactured
- Significant supplychain risk mitigation
- Stable impurity profile and consistent product quality
This example demonstrates how thoughtful process optimization can dramatically improve feasibility, scalability, and costeffectiveness for NCE programs.
A global CDMO partner with integrated capabilities
The webinar also provides an overview of Seqens’ global footprint and capabilities. With 8 pharmaceutical manufacturing sites , including 6 cGMP facilities, Seqens offers endtoend support for:
- Custom APIs and intermediates (lien vers la page Custom manufacturing sur pharma)
- GMP and nonGMP regulatory starting materials
- Potent APIs and complex chemistries
- Generic APIs (lien vers la page du site pharma)
- cGMP polymers for drug delivery and medical devices (lien vers la page custom polymers)
Seqens’ network spans France, Germany, Finland, Israel, and the United States, ensuring proximity, flexibility, and supplychain resilience. The flagship R&D center in Porcheville centralizes advanced technologies, analytical development (lien ITW expert Pirjo), and specialized expertise such as biocatalysis and solid state analysis. (lien ITW expert Julien Leroudier)
Why watch this webinar?
Whether you are a biotech company advancing your first clinical candidate or a pharmaceutical company preparing for commercial launch, this webinar provides actionable guidance to help you:
- Understand the key success factors in API development
- Anticipate technical and regulatory challenges
- Optimize your process for cost, quality, and scalability
- Choose the right CDMO partner for each project phase
Our experts share concrete examples, strategic recommendations, and a transparent view of how Seqens supports customers from labscale synthesis to commercial manufacturing.
Unlock valuable insights to strengthen your API development strategy.
Watch the webinar and discover how Seqens can drive your API to success.
To unlock the webinar, fill the form below. Have a question ? Our experts are here to answer you
